Beyond mRNA: FDA’s Marks Calls For Platform Agnostic Search For Better COVID Vaccines

 
• By Sarah Karlin-Smith

Marks opines on what sponsors would need to do to bring a ‘better’ vaccine to market in a NEJM interview. Meanwhile, CDC releases real world data on estimated bivalent booster efficacy.

Bride running away from groom
FDA’s Peter Marks says it would be a mistake to be ‘wedded’ to early COVID vaccine technology • Source: Shutterstock

More from Vaccines

More from Pink Sheet